CYP1A2 phenotype and genotype in a population from the Carboniferous Region of Coahuila, Mexico

被引:33
作者
Castorena-Torres, F
Mendoza-Cantú, A
de León, MB
Cisneros, B
Zapata-Pérez, O
López-Carrillo, L
Salinas, JE
Albores, A
机构
[1] IPN, Ctr Invest & Estud Avanzados, Secct Externa Toxicol, Mexico City 07360, DF, Mexico
[2] IPN, Ctr Invest & Estud Avanzados, Dept Genet & Mol Biol, Mexico City 07360, DF, Mexico
[3] IPN, Ctr Invest & Estud Avanzados, Dept Ciencias Mar, Mexico City 07360, DF, Mexico
[4] Inst Nacl Salud Publ, Cuernavaca 62508, Morelos, Mexico
[5] Secretarua Salud, Sabinas 26700, Coahuila, Mexico
关键词
CYP1A2; polymorphism; PAH; genotype; phenotype; 1-hydroxypyrene;
D O I
10.1016/j.toxlet.2004.12.005
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
CYP1A2 regulation by polycyclic aromatic hydrocarbons (PAHs) exposure and polymorphism was investigated in 46 male volunteers from the Carboniferous Region in northern Coahuila, Mexico. PAH exposure was estimated by the urinary excretion of 1-hydroxypyrene (1-OHP), whereas the regulatory effects were assessed by the caffeine metabolic ratio (CMR). Genotype was evaluated by determining 5'-flanking region (-2964) and intron I (734) polymorphisms. A statistically significant difference in the urinary 1-OHP geometric means of Barroteran, Cloete and Juarez (2.30, 0.45 and 0.04, respectively) was observed. As for the genotype, the intron I distribution was 0% C/C, 46% C/A and 54% A/A, whereas that of the 5'-flanking region was 26% G/G, 42% G/A and 32% A/A. Both distributions were in agreement with the Hardy-Weinberg equilibrium model. A greater enzyme activity was observed in the A/A compared to C/A individuals according to the CMR (P < 0.001), whereas the 5'-flanking region polymorphism showed no effect on CYP1A2 enzymatic activity. These results suggest that intron I polymorphism and PAH exposure are relevant factors that modulate CYP1A2 enzymatic activity. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:331 / 339
页数:9
相关论文
共 27 条
  • [1] Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication:: Insights into the measurement of hepatic cytochrome P450 1A2 induction
    Abraham, K
    Geusau, A
    Tosun, Y
    Helge, H
    Bauer, S
    Brockmöller, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (02) : 163 - 174
  • [2] CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure
    Alexandrie, AK
    Warholm, M
    Carstensen, U
    Axmon, A
    Hagmar, L
    Levin, JO
    Östman, C
    Rannug, A
    [J]. CARCINOGENESIS, 2000, 21 (04) : 669 - 676
  • [3] Cytochromes P450 and metabolism of xenobiotics
    Anzenbacher, P
    Anzenbacherová, E
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (5-6) : 737 - 747
  • [4] COMPARISON OF CAFFEINE METABOLISM BY SLICES, MICROSOMES AND HEPATOCYTE CULTURES FROM ADULT HUMAN-LIVER
    BERTHOU, F
    RATANASAVANH, D
    RICHE, C
    PICART, D
    VOIRIN, T
    GUILLOUZO, A
    [J]. XENOBIOTICA, 1989, 19 (04) : 401 - 417
  • [5] A URINARY METABOLITE RATIO THAT REFLECTS SYSTEMIC CAFFEINE CLEARANCE
    CAMPBELL, ME
    SPIELBERG, SP
    KALOW, W
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (02) : 157 - 165
  • [6] A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype
    Chida, M
    Yokoi, T
    Nemoto, N
    Inaba, M
    Kinoshita, M
    Kamataki, T
    [J]. PHARMACOGENETICS, 1999, 9 (03): : 287 - 293
  • [7] Organization of the CYP1A cluster on human chromosome 15:: implications for gene regulation
    Corchero, J
    Pimprale, S
    Kimura, S
    Gonzalez, FJ
    [J]. PHARMACOGENETICS, 2001, 11 (01): : 1 - 6
  • [8] Validity of biomarkers in environmental health studies: The case of PAHs and benzene
    Dor, F
    Dab, W
    Empereur-Bissonnet, P
    Zmirou, D
    [J]. CRITICAL REVIEWS IN TOXICOLOGY, 1999, 29 (02) : 129 - 168
  • [9] Impact of phase I or phase II enzyme polymorphisms on lymphocyte DNA adducts in subjects exposed to urban air pollution and environmental tobacco smoke
    Georgiadis, P
    Demopoulos, NA
    Topinka, J
    Stephanou, G
    Stoikidou, M
    Bekyrou, M
    Katsouyianni, K
    Sram, R
    Autrup, H
    Kyrtopoulos, SA
    [J]. TOXICOLOGY LETTERS, 2004, 149 (1-3) : 269 - 280
  • [10] URINARY-EXCRETION OF 1-PYRENOL IN AUTOMOTIVE REPAIR WORKERS
    GRANELLA, M
    CLONFERO, E
    [J]. INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 1993, 65 (04) : 241 - 245